Article Cited by others

REVIEW

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

Mizokami Atsushi, Izumi Kouji, Konaka Hiroyuki, Kitagawa Yasuhide, Kadono Yoshifumi, Narimoto Kazutaka, Nohara Takahiro, Bahl Amit K, Namiki Mikio

Year : 2017| Volume: 19| Issue : 2 | Page no: 143-148

   This article has been cited by
 
1 Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy
Nitesh Kumar Poddar, Disha Agarwal, Yamini Agarwal, Yasanandana Supunsiri Wijayasinghe, Arunima Mukherjee, Shahanavaj Khan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022; : 166524
[Pubmed]  [Google Scholar] [DOI]
2 Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?
Ziyang Xu, Fukun Wei, Jie Wang, Sai Ma, Yi Kan, Bingheng Li, Nienie Qi, Lijun Mao
Cancer Medicine. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study
Kristina Snipaitiene, Arnas Bakavicius, Juozas R. Lazutka, Albertas Ulys, Feliksas Jankevicius, Sonata Jarmalaite
The Prostate. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study
Kenichi Nakajima,Atsushi Mizokami,Hideyasu Matsuyama,Tomohiko Ichikawa,Go Kaneko,Satoru Takahashi,Hiroaki Shiina,Hiroyuki Horikoshi,Katsuyoshi Hashine,Yutaka Sugiyama,Takeshi Miyao,Manabu Kamiyama,Kenichi Harada,Akito Ito
International Journal of Urology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
Tianyu Guo,Yang Wang,Jing Jia,Xueying Mao,Elzbieta Stankiewicz,Glenda Scandura,Edwina Burke,Lei Xu,Jacek Marzec,Caitlin R. Davies,Jiaying Jasmin Lu,Prabhakar Rajan,Alistair Grey,Karen Tipples,John Hines,Sakunthala Kudahetti,Tim Oliver,Thomas Powles,Constantine Alifrangis,Manish Kohli,Greg Shaw,Wen Wang,Ninghan Feng,Jonathan Shamash,Daniel Berney,Liang Wang,Yong-Jie Lu
Frontiers in Cell and Developmental Biology. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
6 The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy
I. G. Rusakov,A. A. Gritskevich,T. P. Baitman,S. V. Mishugin
Meditsinskiy sovet = Medical Council. 2020; (20): 100
[Pubmed]  [Google Scholar] [DOI]
7 SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
Carlos D. Cruz-Hernández,Marian Cruz-Burgos,Sergio A. Cortés-Ramírez,Alberto Losada-García,Ignacio Camacho-Arroyo,Patricia García-López,Elizabeth Langley,Vanessa González-Covarrubias,Monserrat Llaguno-Munive,Martha E. Albino-Sánchez,José L. Cruz-Colín,Carlos Pérez-Plasencia,Fredy O. Beltrán-Anaya,Mauricio Rodríguez-Dorantes
Cancer Cell International. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
8 Resetting the Bar of Castration Resistance – Understanding Androgen Dynamics in Therapy Resistance and Treatment Choice in Prostate Cancer
Neal D. Shore,Alicia K. Morgans,Charles J. Ryan
Clinical Genitourinary Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma
Jun Wang,Mierxiati Abudurexiti,Ning Shao,Yu Wei,Yao Zhu,Ding-wei Ye
European Urology Focus. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 HoxB13 mediates AR-V7 activity in prostate cancer
Héctor I. Navarro,Andrew S. Goldstein
Proceedings of the National Academy of Sciences. 2018; 115(26): 6528
[Pubmed]  [Google Scholar] [DOI]
11 TRIM16 transcription factor in prostate cancer
L. V. Spirina,A. ?. Gorbunov,I. V. Kondakova,E. ?. Slonimskaya,?. A. Usynin,N. V. Tarasenko
Bulletin of Siberian Medicine. 2018; 17(3): 122
[Pubmed]  [Google Scholar] [DOI]
12 Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet
Daniel P. Petrylak,E. David Crawford
Targeted Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
13 Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines
Atsushi Mizokami,Yoshifumi Kadono,Yasuhide Kitagawa,Kouji Izumi,Hiroyuki Konaka
International Journal of Urology. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article